Inventor
Anna M. Wu
Inventor
Sherman Oaks, CA, US
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides30%
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
G01NInvestigating or analysing materials by determining their chemical or physical properties11%
C12NMicroorganisms or enzymes6%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture2%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests2%
PatentTitleYear
10,407,503Fully human antibodies and fragments recognizing human c-Met20199,765,155'Covalent disulfide-linked diabodies and uses thereof'20179,701,754'Covalent disulfide-linked diabodies and uses thereof'20179,624,304'Antibodies which bind to epithelial membrane protein 2 (EMP2)'20179,527,919'High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection'20169,011,857'Methods of treating cancer by administering EMP2 antibodies'20158,940,298'High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection'20158,940,871'Engineered anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting'20158,785,602'EMP2 antibodies and methods of use thereof for causing regression of a solid tumor or symptoms thereof'20148,779,104'EMP2 antibodies and methods of use thereof causing regression of a solid tumor or symptoms thereof'20148,703,920'Fully human antibodies against N-cadherin'20148,404,817'Humanized anti-prostate stem cell antigen monoclonal antibody'20138,378,086'Luciferases and methods for making and using the same'20138,318,906'EMP2 antibodies and their therapeutic uses'20128,258,277'Luciferases and methods for making and using the same'20128,173,791'Luciferases and methods for making and using the same'20128,088,908'Humanized anti-prostate stem cell antigen monoclonal antibody'20128,043,830'Biotin-ligase system for secretion of biotinylated protein'20117,939,649'Polynucleotide encoding luciferase'20117,776,330'Humanized anti-CEA T84.66 antibody and uses thereof'20107,727,525'Engineered anti-CD20 antibody fragments for in vivo targeting and therapeutics'20107,273,608'Humanized anti-CEA T84.66 antibody and uses thereof'20076,410,319'CD20-specific redirected T cells and their use in cellular immunotherapy of CD20 malignancies'20025,837,821'Antibody construct'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998–2017Patents assigned to HOPE CITY (9)· patent assignee history
1998–2019Based in Sherman Oaks, CA, US· patent location history
2010–2019Patents assigned to UNIV CALIFORNIA (16)· patent assignee history
2012–2017Patents assigned to WU ANNA M (11)· patent assignee history
2012–2015Patents assigned to REITER ROBERT E (5)· patent assignee history
2012–2017Patents assigned to SHERMAN MARK A (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV CALIFORNIA | 16 | 2010–2019 |
| WU ANNA Mself | 11 | 2012–2017 |
| HOPE CITY | 9 | 1998–2017 |
| REITER ROBERT E | 5 | 2012–2015 |
| SHERMAN MARK A | 4 | 2012–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Sherman Oaks, California, US | 24 | 1998–2019 |